SCHEMBL125206

SCHEMBL125206

C=CCc1ccccc1[SiH](Cl)Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.42
GABRB2 P47870 2/20 0.42
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 1/20 0.34
AKR1B1 P15121 1/20 0.33
ADRA2C P18825 3/20 0.33
ADRA2B P18089 2/20 0.33
HTR1A P08908 2/20 0.33
ADRA2A P08913 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
ADRB2 P07550 3/20 0.32
ADRB1 P08588 3/20 0.32
LMNA P02545 1/20 0.32
ADRB3 P13945 1/20 0.32
SLC6A2 P23975 1/20 0.32
BDKRB2 P30411 1/20 0.32
SLC6A4 P31645 1/20 0.32
ADRA1A P35348 1/20 0.32
HTR2B P41595 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683893 0.87 GABRA1 (0.34) GABRA1GABRB2ALDH1A1ADRA2CADRA2B
SCHEMBL28730875 0.79 GABRA1 (0.42) GABRA1GABRB2ALDH1A1KDM4EADRA2C
SCHEMBL6841674 0.79 GABRA1 (0.47) GABRA1GABRB2ALDH1A1KDM4EAKR1B1
SCHEMBL173300 0.77 GABRA1 (0.56) GABRA1GABRB2ALDH1A1KDM4EAKR1B1
SCHEMBL29763626 0.77 GABRA1 (0.56) GABRA1GABRB2ALDH1A1KDM4EAKR1B1
SCHEMBL28730873 0.76 GABRA1 (0.40) GABRA1GABRB2ALDH1A1KDM4EADRA2C
SCHEMBL9715900 0.76 USP2 (0.40) ALDH1A1LMNA
SCHEMBL3109867 0.75 GABRA1 (0.39) GABRA1GABRB2ALDH1A1KDM4EADRA2C
SCHEMBL9715844 0.74 TDP1 (0.42) ALDH1A1LMNATSHR
SCHEMBL19437729 0.74 GABRA1 (0.54) GABRA1GABRB2ALDH1A1KDM4EAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352315-A1 METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2024-10-24 US claimed
US-20240010511-A1 METHODS AND COMPOSITIONS FOR SYNTHESIS OF PHOSPHOR AND ITS INCORPORATION IN A POLYMER MATRIX FOR LIGHT CONVERSION SOLGRO, INC. (US) 2024-01-11 US claimed
US-20220363929-A1 INKJET INK COMPOSITION HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2022-11-17 US claimed
US-20210230481-A1 METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2021-07-29 US claimed
WO-2021112819-A1 INKJET INK COMPOSITION HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-06-10 WO claimed
EP-3830020-A1 METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX Board of Regents, The University of Texas System (US) 2021-06-09 EP claimed
CN-112912336-A Methods and compositions for enhancing dispersion of phosphors in a polymer matrix 德克萨斯大学体系董事会 2021-06-04 CN claimed
WO-2020223644-A1 METHODS AND COMPOSITIONS FOR SYNTHESIS OF PHOSPHOR AND ITS INCORPORATION IN A POLYMER MATRIX FOR LIGHT CONVERSION SOLGRO, INC. (US) 2020-11-05 WO claimed
WO-2020028889-A1 METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX BOARDS OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-02-06 WO claimed
EP-3153518-B1 MONO-FUNCTIONAL BRANCHED ORGANOSILOXANE COMPOUND AND METHOD FOR PRODUCING THE SAME SHINETSU CHEMICAL CO (JP) 2018-04-18 EP claimed
EP-2276793-A1 SULFUR MODIFIED SILANES FOR THE ELABORATION OF HIGH REFRACTIVE INDEX MATERIALS Essilor International (Compagnie Générale d'Optique) (FR) 2011-01-26 EP claimed
WO-2009138853-A1 SULFUR MODIFIED SILANES FOR THE ELABORATION OF HIGH REFRACTIVE INDEX MATERIALS ESSILOR INTERNATIONAL (FR) 2009-11-19 WO claimed
US-20060173145-A1 Multi-functionalized high-trans elastomeric polymers BRIDGESTONE CORPORATION (JP) 2006-08-03 US claimed
EP-0801334-B1 Magnetic coated carrier, two-component type developer and developing method CANON KK (JP) 2001-08-29 EP claimed
EP-0801335-B1 Magnetic coated carrier, two-component type developer and developing method CANON KK (JP) 2001-08-29 EP claimed
US-6165663-A Magnetic coated carrier two-component type developer and developing method CANON KABUSHIKI KAISHA (JP) 2000-12-26 US claimed
US-5766814-A Magnetic coated carrier, two-component type developer and developing method CANNON KABUSHIKI KAISHA (JP) 1998-06-16 US claimed
WO-1998020395-A1 METHOD OF APPLYING DRY FILM PHOTORESIST W.L. GORE & ASSOCIATES, INC. (US) 1998-05-14 WO claimed
EP-0801335-A1 Magnetic coated carrier, two-component type developer and developing method CANON KABUSHIKI KAISHA (JP) 1997-10-15 EP claimed
EP-0801334-A1 Magnetic coated carrier, two-component type developer and developing method CANON KABUSHIKI KAISHA (JP) 1997-10-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173145-A1 Multi-functionalized high-trans elastomeric polymers VCL, PUF60, JMJD6 GABRA1 2056/4885GABRB2 2769/4885ALDH1A1 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.